Palisade Bio PALI
NASDAQ PALI
$2.09 +0.04 (+2.20%)
At close: Sep 4, 2026 · 4:00 PM EDT

Palisade Bio (PALI) Receivables - Net (2011 - 2026)

Palisade Bio (PALI) posted quarterly Receivables - Net of $250000.0 for Q1 2023, up 323.73% quarter-over-quarter from $59000.0 in Q2 2021.

Analysis

Palisade Bio (PALI) Receivables - Net (2011 - 2026) Analysis & Trends

Palisade Bio (PALI) has reported Receivables - Net for 12 consecutive years, with $250000.0 the latest figure, recorded in Q1 2023.

  • In Q1 2023, Receivables - Net changed N/A year-over-year to $250000.0; the TTM figure through Mar 2023 stood at $250000.0 (changed N/A YoY), while the FY2020 annual figure was $59000.0, up 180.1% from the prior year.
  • Receivables - Net rose to $250000.0 in Q1 2023 per PALI's latest filing, from $59000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $250000.0 in Q1 2023 and bottomed at $8779.0 in Q3 2020.
  • Historically, Receivables - Net has averaged $84354.1 across 4 years, with a median of $59000.0 in 2020.
  • Annual changes were most pronounced in 2019 — Receivables - Net plunged 92.84% — and 2021, when it jumped 248.33%.
  • Palisade Bio's Receivables - Net stood at $21064.0 in 2019, then jumped by 180.1% to $59000.0 in 2020, then changed by 0.0% to $59000.0 in 2021, then surged by 323.73% to $250000.0 in 2023.
  • Business Quant data shows PALI's Receivables - Net at $250000.0 in Q1 2023, $59000.0 in Q2 2021, and $25259.0 in Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Palisade Bio 440.73 Mn 315.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 500,000.00
Mar 31, 2023 300,000.00
Jun 30, 2021 59,000.00
Mar 31, 2021 25,259.00
Dec 31, 2020 59,000.00
Sep 30, 2020 8,779.00
Jun 30, 2020 16,938.00
Mar 31, 2020 19,014.00
Dec 31, 2019 21,064.00
Sep 30, 2019 61,154.00
Jun 30, 2019 169,905.00
Mar 31, 2019 237,782.00
Dec 31, 2018 294,057.00
Sep 30, 2018 161,979.00
Jun 30, 2018 478,722.00
Mar 31, 2018 137,372.00
Dec 31, 2017 312,802.00
Sep 30, 2017 37,458.00
Jun 30, 2017 5,345.00
Mar 31, 2017 14,715.00